{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:14:45Z","timestamp":1793657685627,"version":"4.5.1"},"reference-count":144,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.autrev.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:23:00Z","timestamp":1559938980000},"page":"786-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Epidermolysis bullosa acquisita: A comprehensive review"],"prefix":"10.1016","volume":"18","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kneiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Valdebran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0190-9622(84)80459-4","article-title":"Epidermolysis bullosa acquisita--a pemphigoid-like disease","volume":"11","author":"Gammon","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","article-title":"Epidermolysis bullosa acquisita. Report of three cases and review of all published cases","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/812029","article-title":"Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita","volume":"2013","author":"Ludwig","year":"2013","journal-title":"ISRN Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0190-9622(82)80319-8","article-title":"Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease","volume":"7","author":"Gammon","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0025","first-page":"10","article-title":"Two cases of epidermolysis bullosa","volume":"13","author":"Elliot","year":"1895","journal-title":"Cutan Genitourin Dis"},{"issue":"9","key":"10.1016\/j.autrev.2019.06.007_bb0030","first-page":"1143","article-title":"The immunopathology of epidermolysis bullosa acquisita","volume":"108","author":"Kushniruk","year":"1973","journal-title":"Can Med Assoc J"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1980.tb06550.x","article-title":"Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients","volume":"102","author":"Nieboer","year":"1980","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1523-1747.ep12526124","article-title":"Epidermolysis bullosa acquisita: ultrastructural and immunological studies","volume":"76","author":"Yaoita","year":"1981","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4103\/ijdvl.IJDVL_678_16","article-title":"Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin","volume":"83","author":"Goyal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"10.1016\/j.autrev.2019.06.007_bb0050","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/jid.2011.231","article-title":"Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita","volume":"131","author":"Zumelzu","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2019.06.007_bb0055","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and Pemphigoid diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1523-1747.ep12470317","article-title":"Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated","volume":"91","author":"Gammon","year":"1988","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000246282","article-title":"Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita","volume":"193","author":"Lee","year":"1996","journal-title":"Dermatology."},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjd.16138","article-title":"International bullous diseases group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","volume":"179","author":"Prost-Squarcioni","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0080","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0085","first-page":"995","article-title":"Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study","volume":"14","author":"Milinkovi\u0107","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous diseases French study group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2019.06.007_bb0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/1744666X.2016.1196136","article-title":"Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University","volume":"12","author":"Hashimoto","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1346-8138.13546","article-title":"Coexistence of acquired hemophilia a and epidermolysis bullosa acquisita: two case reports and published work review","volume":"44","author":"Yan","year":"2017","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/0001555558241244","article-title":"Epidermolysis bullosa acquisita and Crohn's disease","volume":"58","author":"Livden","year":"1978","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(82)70017-9","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease","volume":"6","author":"Ray","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0115","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/bjd.13144","article-title":"Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain","volume":"171","author":"Iranzo","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.2010.03845.x","article-title":"Clinical and immunopathological evaluation of epidermolysis bullosa acquisita","volume":"36","author":"Delgado","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"25","key":"10.1016\/j.autrev.2019.06.007_bb0125","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.3748\/wjg.v22.i25.5655","article-title":"Oral pathology in inflammatory bowel disease","volume":"22","author":"Muhvi\u0107-Urek","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12328-017-0759-7","article-title":"The endoscopic findings of the upper gastrointestinal tract in patients with Crohn's disease","volume":"10","author":"Nomura","year":"2017","journal-title":"Clin J Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0135","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","article-title":"The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen","volume":"118","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ced.12114","article-title":"Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature","volume":"38","author":"Reddy","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis Bullosa Acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI113373","article-title":"Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen","volume":"81","author":"Woodley","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.06.007_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2172-13-16","article-title":"Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases","volume":"13","author":"Licarete","year":"2012","journal-title":"BMC Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1083\/jcb.104.3.611","article-title":"Type VII collagen forms an extended network of anchoring fibrils","volume":"104","author":"Keene","year":"1987","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0165","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1083\/jcb.103.4.1577","article-title":"Type VII collagen is a major structural component of anchoring fibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J Cell Biol"},{"issue":"16","key":"10.1016\/j.autrev.2019.06.007_bb0170","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1073\/pnas.88.16.6931","article-title":"Human type VII collagen: cDNA cloning and chromosomal mapping of the gene","volume":"88","author":"Parente","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1346-8138.14222","article-title":"Epidermal aspects of type VII collagen: implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita","volume":"45","author":"Watanabe","year":"2018","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjd.13224","article-title":"Oesophageal involvement in epidermolysis bullosa acquisita","volume":"172","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0185","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2133.1999.03163.x","article-title":"Ocular involvement in IgA-epidermolysis bullosa acquisita","volume":"141","author":"Bauer","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9440(10)64182-X","article-title":"Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin","volume":"161","author":"Sitaru","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0195","article-title":"Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita","author":"Koga","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep38357","article-title":"T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita","volume":"6","author":"Bieber","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/path.2857","article-title":"Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita","volume":"224","author":"Ishii","year":"2011","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.4062","article-title":"Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease","volume":"228","author":"Hashimoto","year":"2012","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/path.4023","article-title":"Genetic identification and functional validation of Fc\u03b3RIV as key molecule in autoantibody-induced tissue injury","volume":"228","author":"Kasperkiewicz","year":"2012","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.2973","article-title":"Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita","volume":"225","author":"Kopecki","year":"2011","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.autrev.2019.06.007_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071116","article-title":"Cytoskeletal regulation of inflammation and its impact on skin blistering disease Epidermolysis Bullosa Acquisita","volume":"17","author":"Kopecki","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0006-291X(05)81118-0","article-title":"Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture","volume":"180","author":"Ryyn\u00e4nen","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1083\/jcb.117.3.679","article-title":"Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro","volume":"117","author":"K\u00f6nig","year":"1992","journal-title":"J Cell Biol"},{"issue":"21","key":"10.1016\/j.autrev.2019.06.007_bb0245","doi-asserted-by":"crossref","first-page":"13053","DOI":"10.1074\/jbc.273.21.13053","article-title":"Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta","volume":"273","author":"Vindevoghel","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2019.06.007_bb0250","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3021","article-title":"Direct immunofluorescence of mechanobullous epidermolysis bullosa acquisita, porphyria cutanea tarda and pseudoporphyria","author":"de Groot","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0255","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archderm.1959.01560240065008","article-title":"Epidermolysis bullosa acquisita (tardive) and porphyria cutanea tarda: an analytic comparison of these two conditions","volume":"80","author":"JH","year":"1959","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/00015555-1065","article-title":"Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.02.005","article-title":"Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy","author":"Buonavoglia","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2019.06.007_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1834-7819.2010.01196.x","article-title":"Oral mucosal diseases: the inflammatory dermatoses","volume":"55","author":"Schifter","year":"2010","journal-title":"Aust Dent J"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0275","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.autrev.2017.12.009","article-title":"From HSV infection to erythema multiforme through autoimmune crossreactivity","volume":"17","author":"Lucchese","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0280","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Ba\u011fc\u0131","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0285","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0295","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2133.1996.tb07624.x","article-title":"A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies","volume":"134","author":"Hashimoto","year":"1996","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0300","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1067\/mjd.2002.125079","article-title":"IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature","volume":"47","author":"Vodegel","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0305","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.1991.01680030111016","article-title":"Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid","volume":"127","author":"Kurzhals","year":"1991","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0190-9622(93)70016-M","article-title":"Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?","volume":"28","author":"Joly","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0315","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000017958","article-title":"A case of an inflammatory variant of epidermolysis bullosa acquisita: chronic bullous dermatosis associated with nonscarring mucosal blisters and circulating IgG anti-type-VII-collagen antibody","volume":"197","author":"Tokuda","year":"1998","journal-title":"Dermatology."},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0325","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/jdv.12096","article-title":"Epidermolysis bullosa acquisita","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0335","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ad.2013.05.005","article-title":"Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients","volume":"104","author":"Barreiro-Capurro","year":"2013","journal-title":"Actas Dermosifiliogr"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2019.06.007_bb0340","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0345","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.det.2011.03.001","article-title":"Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases","volume":"29","author":"Pohla-Gubo","year":"2011","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0350","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0190-9622(92)70235-8","article-title":"Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid","volume":"27","author":"Smoller","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0355","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archderm.138.10.1385","article-title":"IgM-mediated epidermolysis bullosa acquisita","volume":"138","author":"Suchniak","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0360","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000018328","article-title":"Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection","volume":"200","author":"Lee","year":"2000","journal-title":"Dermatology."},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.11.029","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.12308","article-title":"The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0380","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 Mol\/L salt-split skin. Specificity, sensitivity, and practical considerations","volume":"35","author":"Lazarova","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archderm.135.5.569","article-title":"Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen","volume":"135","author":"Chan","year":"1999","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0390","first-page":"768","article-title":"Autoantibody profile of a cohort of 78 Italian patients with mucous membrane Pemphigoid: correlation between reactivity profile and clinical involvement","volume":"96","author":"Cozzani","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0395","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/bjd.15800","article-title":"Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis","volume":"177","author":"Schmidt","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0400","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1067\/mjd.2003.99","article-title":"Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy","volume":"48","author":"Vodegel","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0405","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0410","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2016.01.005","article-title":"Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA)","volume":"74","author":"Seta","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0415","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjd.12300","article-title":"Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2019.06.007_bb0425","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.12278","article-title":"Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita","volume":"40","author":"Ito","year":"2013","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0430","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjd.12011","article-title":"Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study","volume":"168","author":"Marzano","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0435","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0190-9622(86)70181-3","article-title":"Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen","volume":"15","author":"Barton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00570","article-title":"Anti-type VII collagen antibodies are identified in a subpopulation of bullous Pemphigoid patients with relapse","volume":"9","author":"Giusti","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0455","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00403-016-1632-0","article-title":"The use of biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita","volume":"308","author":"Marzano","year":"2016","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0460","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","article-title":"Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping","volume":"132","author":"De Jong","year":"1996","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0465","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI116774","article-title":"Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa","volume":"92","author":"Lapiere","year":"1993","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0470","first-page":"133","article-title":"The value of type IV collagen Immunohistochemical staining in the differential diagnosis of autoimmune subepidermal bullous diseases","volume":"26","author":"Yeol Lee","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0475","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0560.1990.tb00109.x","article-title":"Location of basement membrane type IV collagen beneath subepidermal bullous diseases","volume":"17","author":"Pardo","year":"1990","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0480","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ad.2015.10.019","article-title":"Usefulness of a simple Immunohistochemical staining technique to differentiate anti-p200 Pemphigoid from other autoimmune blistering diseases: a report of 2 cases","volume":"108","author":"Garc\u00eda-D\u00edez","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0485","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jaad.2008.12.020","article-title":"A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine","volume":"61","author":"Tanaka","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2019.06.007_bb0490","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1346-8138.13395","article-title":"Oral colchicine monotherapy for epidermolysis bullosa acquisita: mechanism of action and efficacy","volume":"43","author":"Adachi","year":"2016","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0495","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00375841","article-title":"Epidermolysis bullosa acquisita--successful treatment with colchicine","volume":"286","author":"Megahed","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2019.06.007_bb0500","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210210","article-title":"Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease","volume":"2015","author":"Russo","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0505","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1346-8138.2005.tb00727.x","article-title":"Remission of recalcitrant epidermolysis bullosa acquisita (EBA) with colchicine monotherapy","volume":"32","author":"Arora","year":"2005","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0510","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2340\/00015555-1163","article-title":"A case of epidermolysis bullosa acquisita associated with laryngeal stenosis","volume":"92","author":"Kiniwa","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.autrev.2019.06.007_bb0515","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/14656566.2011.549127","article-title":"Current concepts in the treatment of epidermolysis bullosa acquisita","volume":"12","author":"G\u00fcrcan","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0520","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/120347540100500505","article-title":"Epidermolysis bullosa acquisita responsive to dapsone therapy","volume":"5","author":"Hughes","year":"2001","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"10.1016\/j.autrev.2019.06.007_bb0525","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2340\/00015555-2110","article-title":"Childhood epidermolysis bullosa acquisita with underlying coeliac disease","volume":"95","author":"Kasperkiewicz","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"10.1016\/j.autrev.2019.06.007_bb0530","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/1346-8138.12958","article-title":"Inflammatory epidermolysis bullosa acquisita in a 4-year-old girl","volume":"42","author":"Lazi\u0107-Mosler","year":"2015","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0535","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2340\/00015555-1804","article-title":"Inflammatory epidermolysis bullosa acquisita effectively treated with minocycline","volume":"94","author":"Kawase","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2019.06.007_bb0540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology."},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2019.06.007_bb0545","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus."},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0550","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jaad.2005.07.009","article-title":"Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent","volume":"54","author":"Tran","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0555","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jdcr.2015.07.007","article-title":"Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up","volume":"1","author":"Sami","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0560","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1468-3083.2001.00174-2.x","article-title":"Epidermolysis bullosa acquisita responsive to cyclosporin therapy","volume":"15","author":"Khatri","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0565","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2230.1993.tb01028.x","article-title":"Epidermolysis bullosa acquisita--a case with upper airways obstruction requiring tracheostomy and responding to cyclosporin","volume":"18","author":"Clement","year":"1993","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0570","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1684\/ejd.2017.3118","article-title":"Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita","volume":"27","author":"Komori","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0575","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaad.2006.06.029","article-title":"High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases","volume":"56","author":"Segura","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0580","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases","volume":"340","author":"Yu","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0585","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0590","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.134.1.80","article-title":"Dermatological uses of high-dose intravenous immunoglobulin","volume":"134","author":"Jolles","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0595","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/1097-0142(19910915)68:6+<1430::AID-CNCR2820681405>3.0.CO;2-4","article-title":"Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases","volume":"68","author":"Ballow","year":"1991","journal-title":"Cancer."},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0600","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1590\/S0365-05962010000400014","article-title":"Intravenous immunoglobulin for treatment of severe acquired bullous epidermolysis refractory to conventional immunosuppressive therapy","volume":"85","author":"Mosqueira","year":"2010","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0605","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0190-9622(97)80411-2","article-title":"Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita","volume":"36","author":"Kofler","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.autrev.2019.06.007_bb0610","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1468-3083.2011.04205.x","article-title":"Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up","volume":"26","author":"Ahmed","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2019.06.007_bb0615","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0620","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.143.2.192","article-title":"Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)","volume":"143","author":"Niedermeier","year":"2007","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.06.007_bb0625","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12726","article-title":"The use of rituximab in treatment of epidermolysis bullosa acquisita: three new cases and a review of the literature","volume":"31","author":"Bevans","year":"2018","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2019.06.007_bb0630","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/09546634.2016.1179711","article-title":"Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy","volume":"28","author":"Oktem","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.autrev.2019.06.007_bb0635","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00018-009-0256-3","article-title":"Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII","volume":"67","author":"Csorba","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.autrev.2019.06.007_bb0640","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2019.06.007_bb0645","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0650","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.0901412","article-title":"T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita","volume":"184","author":"Sitaru","year":"2010","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0655","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/jid.2013.91","article-title":"Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation","volume":"133","author":"Hellberg","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0660","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-013-8361-3","article-title":"The implication of vitamin D and autoimmunity: a comprehensive review","volume":"45","author":"Yang","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0665","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jid.2017.09.009","article-title":"Calcitriol treatment ameliorates inflammation and blistering in mouse models of Epidermolysis Bullosa Acquisita","volume":"138","author":"Tukaj","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"168","key":"10.1016\/j.autrev.2019.06.007_bb0670","doi-asserted-by":"crossref","first-page":"ra23","DOI":"10.1126\/scisignal.2001617","article-title":"PI3K\u03b2 plays a critical role in neutrophil activation by immune complexes","volume":"4","author":"Kulkarni","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.autrev.2019.06.007_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01558","article-title":"Therapeutic effect of a novel Phosphatidylinositol-3-kinase \u03b4 inhibitor in experimental Epidermolysis Bullosa Acquisita","volume":"9","author":"Koga","year":"2018","journal-title":"Front Immunol"},{"issue":"266","key":"10.1016\/j.autrev.2019.06.007_bb0680","first-page":"238","article-title":"TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent","volume":"3","author":"Smart","year":"1994","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.autrev.2019.06.007_bb0685","first-page":"123","article-title":"Cytokines and bullous pemphigoid","volume":"10","author":"D'Auria","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.autrev.2019.06.007_bb0690","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2119\/molmed.2015.00206","article-title":"Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment","volume":"22","author":"Hirose","year":"2017","journal-title":"Mol Med"},{"issue":"12","key":"10.1016\/j.autrev.2019.06.007_bb0695","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/exd.13335","article-title":"Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita","volume":"26","author":"Ludwig","year":"2017","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2019.06.007_bb0700","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.4049\/jimmunol.174.12.8082","article-title":"Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes","volume":"174","author":"Oger","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2019.06.007_bb0705","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jid.2016.06.619","article-title":"PDE4 inhibition as potential treatment of Epidermolysis Bullosa Acquisita","volume":"136","author":"Koga","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2019.06.007_bb0710","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0715","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2014.453","article-title":"Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita","volume":"135","author":"Hirose","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.06.007_bb0720","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/jid.2014.451","article-title":"Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita","volume":"135","author":"Iwata","year":"2015","journal-title":"J Invest Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:33Z","timestamp":1761599673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721930134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":144,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S156899721930134X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.06.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermolysis bullosa acquisita: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}